[Screening and detection of tetrazepam and its major metabolites].
The paper describes a screening procedure for 7-Chloro-1,3-dihydro-1-methyl-5-(cyclohexene-1-yl)-2H-1,4-benzodiazepine -2-one (Tetrazepam, Musaril) and other important analytical data (TLC, GLC, UV-, IR-, and mass spectra).
Schütz
H
H
Ebel
S
S
Fitz
H
H
D014151:Anti-Anxiety Agents / Q000378:metabolism*; D001569:Benzodiazepines; D001570:Benzodiazepinones / Q000378:metabolism* / Q000652:urine; D001711:Biotransformation; D055598:Chemical Phenomena; D002621:Chemistry; D002849:Chromatography, Gas; D002855:Chromatography, Thin Layer; D006801:Humans; D006868:Hydrolysis; D013058:Mass Spectrometry; D013056:Spectrophotometry, Ultraviolet
D014151:Anti-Anxiety Agents; D001570:Benzodiazepinones; D001569:Benzodiazepines; C005245:tetrazepam
Screening und Nachweis von Tetrazepam und seinen Hauptmetaboliten.